In ovarian cancer, the activation of NF-κB enhances the aggressiveness of tumor, facilitates the formation of an immune-evasive microenvironment, and recruits pro-tumorigenic immune cells, which in turn promote the survival and metastasis of cancer cells [53, 54]. Here, NFKB1 is linked to cancer.